JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • April 4th, 2023 • BioXcel Holdings, Inc. • Pharmaceutical preparations
Each of the undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. Each of the undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he, her or it knows or has reason to believe that such information is inaccurate.
BIOXCEL HOLDINGS, INC. STOCKHOLDERS AGREEMENTStockholders Agreement • April 4th, 2023 • BioXcel Holdings, Inc. • Pharmaceutical preparations • New York
This STOCKHOLDERS AGREEMENT (this “Agreement”) is made as of April 3, 2023, by and among, BIOXCEL HOLDINGS, INC., a corporation organized under the laws of the State of Delaware (the “Corporation”), DR. KRISHNAN NANDABALAN (and together with the persons identified on Schedule A hereto as an Affiliated Principal Stockholder, collectively, the “Principal Stockholder”), and certain other holders of the Corporation’s Stock (defined below) identified on Schedule A (which Schedule A includes the number of shares of Stock held of record by each Stockholder), each referred to herein as an “Additional Stockholder”). The Principal Stockholder and each Additional Stockholder, are each referred to herein as a “Stockholder,” and collectively, the “Stockholders.”
